History price
|
|
Date | Price | Change | Volume | Avg. Buy | Avg. Sell | Foreign Buy | Foreign Sell |
21/11/24 |
28,800 |
0 ■(0.00%)
| 0 | 733.33 | 200 | - | - |
20/11/24 |
28,800 |
0 ■(0.00%)
| 0 | 914.29 | 150 | - | - |
19/11/24 |
28,800 |
0 ■(0.00%)
| 0 | 928.57 | 100 | - | - |
18/11/24 |
28,800 |
0 ■(0.00%)
| 0 | 1,425 | 100 | - | - |
15/11/24 |
28,800 |
-4,900 ▼(-14.54%)
| 100 | 140 | 100 | - | 100 |
|
|
|
|
Industry Peers |
|
|
|
|
News
|
|
|
|
Download documents
|
|
|
|
Overview
|
|
Contact
|
Listing Inf.
|
Business Reg.
|
Additional Inf.
|
Events
|
Notes
|
|
|
|
Name
|
Danapha Pharmaceutical Joint Stock Company |
English Name
|
Danapha Pharmaceutical Joint Stock Company |
Abbreviation
|
DANAPHA
|
Address
|
253 Dũng Sĩ Thanh Khê - Q.Thanh Khê - Tp.Đà Nẵng |
Telephone (Tel)
|
(84.236) 376 0126 |
Fax
|
(84.236) 376 0127 |
Email
|
info@danapha.com
|
Website
|
http://www.danapha.com
|
Exchange
|
UPCoM |
Sector
|
Manufacturing |
Industry
|
Chemical - Pharmaceutical |
Listing date
|
12/22/2021 |
Chartered capital
|
209,380,000,000 |
Shares listed
|
20,938,000 |
Shares outstanding
|
20,938,000
|
Status
|
Operating |
Tax code
|
0400102091 |
Establishment License
|
0400102091 |
Issued date
|
12/20/2006 |
Business license
|
400102091 |
Issued date
|
06/20/2006 |
Main business scope
|
- Sản xuất, kinh doanh và XNK các mặt hàng thuốc chữa bệnh, mỹ phẩm, nguyên liệu sản xuất thuốc và bao bì dược phẩm - Tổ chức các chương trình nghiên cứu khoa học và cung ứng nguồn nguyên liệu chủ yếu cho nền sản xuất dược phẩm Việt Nam... |
|
|
05/09/2024 09:00
|
DAN Dividend payment in cash with 7.00% for 2023 (Record date)
|
Location
: Securities Companies
|
|
05/09/2024 09:00
|
DAN Dividend payment in cash with 7.00% for 2023
|
Location
: Securities Companies
|
|
05/07/2024 09:00
|
DAN General Meeting of Shareholders for 2024
|
Location
: No.253 - Dung Si Thanh Khe Street -Thanh Khe Tay Ward - Thanh Khe Dist. - Da Nang City
|
|
Items
|
Unit
|
Price |
VND
|
Volume |
Shares
|
Foreigner's, Yield |
% |
Mkt Cap |
bVND
|
Financial indicators |
mVND |
EPS, BVPS, Dividend |
VND
|
P/E, F P/E, P/B
|
Times
|
ROS, ROA, ROE |
%
|
1. The accounting period for equitization year was calculated as of company's establishment date. 2. F PE bases on corporate earnings targets, which are announced by listed companies. 3. 3-month/6-month/12-month price charts was was compiled from revised data.
|
|